Immune recognition of tumor cells and priming of CD8 T-cell responses in the tumor draining lymph node requires processing and presentation of tumor antigens by cross-presenting dendritic cells, coupled with their activation by danger signals, and secretion of type 1 interferons (2, 3). This evidence concerns the gene CD8A and neoplasm.